Exocrine pancreatic insufficiency

This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these messages) This article needs more reliable medical references for verification or relies too heavily on primary sources. Please review the contents of the article and add the appropriate references if you can. Unsourced or poorly sourced material may be challenged and removed. Find sources: "Exocrine pancreatic insufficiency" – news · newspapers · books · scholar · JSTOR (July 2014) This article relies excessively on references to primary sources. Please improve this article by adding secondary or tertiary sources. Find sources: "Exocrine pancreatic insufficiency" – news · newspapers · books · scholar · JSTOR (July 2014) (Learn how and when to remove this message) (Learn how and when to remove this message)

Exocrine pancreatic insufficiency
Anatomy of the pancreas
Specialty	Endocrinology, gastroenterology
Causes	Diabetes (Type 2), Type 1 Diabetes, Pancreatitis, Celiac, Cystic Fibrosis, IBS-D, IBD, somatostatin analogues
Risk factors	older age, tobacco use, alcohol use
Diagnostic method	Fecal elastase test
Treatment	pancreatic enzyme replacement therapy (PERT)
Medication	pancrelipase

Exocrine pancreatic insufficiency (EPI) is the inability to properly digest food due to a lack or reduction of digestive enzymes made by the pancreas. EPI can occur in humans and is prevalent in many conditions^[1] such as cystic fibrosis,^[2] Shwachman–Diamond syndrome,^[3] different types of pancreatitis,^[4] multiple types of diabetes mellitus (Type 1 and Type 2 diabetes),^[5] advanced renal disease,^[6] older adults,^[7] celiac disease,^[8] IBS-D,^[9] IBD,^[10] HIV,^[11] alcohol-related liver disease,^[12] Sjogren syndrome,^[13] tobacco use,^[14] and use of somatostatin analogues.^[15]

EPI is caused by a progressive loss of the pancreatic cells that make digestive enzymes. Loss of digestive enzymes leads to maldigestion and malabsorption of nutrients from normal digestive processes. EPI can cause symptoms even before reaching the stages of malnutrition: 'mild' or 'moderate' EPI is when fecal elastase levels are <200 ug/g, whereas 'severe' EPI is considered to be when fecal elastase levels is <100 ug/g.^[16]

The exocrine pancreas is a portion of this organ that contains clusters of ducts (acini) producing bicarbonate anion, a mild alkali, as well as an array of digestive enzymes that together empty by way of the interlobular and main pancreatic ducts into the duodenum (upper small intestine).^[17] The hormones cholecystokinin and secretin secreted by the stomach and duodenum in response to distension and the presence of food in turn stimulate the production of digestive enzymes by the exocrine pancreas.^[18] The alkalization of the duodenum neutralizes the acidic chyme produced by the stomach that is passing into it; the digestive enzymes serve to catalyze the breakdown of complex foodstuffs into smaller molecules for absorption and integration into metabolic pathways.^[18] The enzymes include proteases (trypsinogen and chymotrypsinogen), hydrolytic enzymes that cleave lipids (the lipases phospholipase A2 and lysophospholipase, and cholesterol esterase), and amylase to digest starches. EPI results from progressive failure in the exocrine function of the pancreas to provide its digestive enzymes, often in response to a genetic condition or other disease state, resulting in the inability of the animal involved to properly digest food.^{[citation needed]}